Profilo
Anthony L. Boral è vicepresidente esecutivo dello sviluppo clinico alla Blueprint Medicines Corp. Nella sua carriera passata ha occupato la posizione di vicepresidente della ricerca clinica oncologica alla Millennium Pharmaceuticals, Inc. e di direttore esecutivo della ricerca clinica oncologica al Novartis Institutes for Biomedical Research, Inc. Ha ricevuto un dottorato dall'Albert Einstein College of Medicine, Inc. e una laurea presso la Wesleyan University.
Precedenti posizioni note di Anthony Boral
| Società | Posizione | Fine |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Direttore Tecnico/Scientifico/R&S | 11/01/2021 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01/02/2015 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01/10/2010 |
Formazione di Anthony Boral
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Wesleyan University
Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
















